| Source: |
| Type: |
| Enhance the immune response in patients. |
| 5270- | 5-ALA, | PDT, | 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy |
| - | Review, | Var, | NA |
| 5431- | AG, | Advances in research on the anti-tumor mechanism of Astragalus polysaccharides |
| - | Review, | Var, | NA |
| 5432- | AG, | Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies |
| - | Review, | Cerv, | NA |
| 5434- | AG, | Recent Advances in the Mechanisms and Applications of Astragalus Polysaccharides in Liver Cancer Treatment: An Overview |
| - | Review, | Liver, | NA |
| 7400- | Amla, | Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer |
| - | Review, | Var, | NA |
| 5409- | ASA, | Role of aspirin in cancer prevention |
| - | Review, | Var, | NA |
| 5572- | B-Gluc, | The Effects of Orally Administered Beta-Glucan on Innate Immune Responses in Humans, a Randomized Open-Label Intervention Pilot-Study |
| - | Study, | Nor, | NA |
| 5571- | B-Gluc, | immuno, | Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review |
| - | Review, | Var, | NA |
| 5570- | B-Gluc, | Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1 |
| - | Review, | Var, | NA |
| 5569- | B-Gluc, | Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response |
| - | in-vitro, | CRC, | NA |
| 5568- | B-Gluc, | immuno, | Beta-glucans in oncology: revolutionizing treatment with immune power & tumor targeting |
| - | Review, | Var, | NA |
| 5567- | B-Gluc, | Trained immunity: A new player in cancer immunotherapy |
| - | Review, | Var, | NA |
| 5566- | B-Gluc, | The effects of beta-glucan on human immune and cancer cells |
| - | Review, | Var, | NA |
| 5575- | B-Gluc, | The effects of β-glucan on human immune and cancer cells |
| - | Review, | Var, | NA |
| 5577- | B-Gluc, | Lentinan progress in inflammatory diseases and tumor diseases |
| - | Review, | Var, | NA | - | Review, | IBD, | NA |
| 5579- | B-Gluc, | Fungal beta-glucans as adjuvants for treating cancer patients – A systematic review of clinical trials |
| - | Review, | Var, | NA |
| 5580- | B-Gluc, | Lentinan, a Shiitake Mushroom β-Glucan, Downregulates the Enhanced PD-L1 Expression Induced by Platinum Compounds in Gastric Cancer Cells |
| - | in-vitro, | GC, | MKN45 |
| 5517- | BEV, | Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors |
| - | Review, | Var, | NA |
| 5622- | Bif, | Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice |
| - | in-vivo, | Var, | NA |
| 5626- | Bif, | Bifidobacterium in anticancer immunochemotherapy: friend or foe? |
| - | Review, | Var, | NA |
| 5628- | Bif, | immuno, | Bifidobacterium modulation of tumor immunotherapy and its mechanism |
| - | Review, | Var, | NA |
| 5680- | BML, | Anticancer properties of bromelain: State-of-the-art and recent trends |
| - | Review, | Var, | NA |
| 5646- | BP, | Black Phosphorus, an Emerging Versatile Nanoplatform for Cancer Immunotherapy |
| - | Review, | Var, | NA |
| 5739- | Buty, | Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review) |
| - | Review, | Var, | NA |
| 5735- | Buty, | Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease |
| - | Study, | Nor, | NA |
| 5837- | CAP, | Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression |
| - | in-vitro, | lymphoma, | PEL |
| 5916- | Cats, | Chemo, | Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial |
| - | Trial, | BC, | NA |
| 6030- | CGA, | Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-453 | - | in-vitro, | Nor, | MCF10 |
| 5980- | Chit, | Chitosan-based nanosystems for cancer diagnosis and therapy: Stimuli-responsive, immune response, and clinical studies |
| - | Review, | Var, | NA |
| 5988- | Chit, | Chitosan immunomodulation: insights into mechanisms of action on immune cells and signaling pathways |
| - | Review, | Var, | NA |
| 5989- | Chit, | Chitosan: A review of molecular structure, bioactivities and interactions with the human body and micro-organisms |
| - | Review, | Var, | NA |
| 5997- | Chit, | Using immunoadjuvant agent glycated chitosan to enhance anti-cancer stem like cell immunity induced by HIFU |
| - | in-vivo, | Lung, | NA |
| 5993- | Chit, | In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy |
| - | in-vitro, | Var, | NA |
| 6374- | CPLE, | Antiviral & platelet-protective properties of Carica papaya in dengue |
| - | Review, | Nor, | NA |
| 6520- | CRV, | Health Benefits and Pharmacological Properties of Carvone |
| - | Review, | Nor, | NA |
| 6203- | Cuc, | immuno, | Isocucurbitacin B targets STAT3 to induce ferroptosis and promote anti-PD1 immunotherapy responses in breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 | - | in-vivo, | BC, | 4T1 |
| 6214- | CUR, | Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve |
| 6223- | CUR, | Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects |
| - | Review, | Var, | NA |
| 6221- | CUR, | Oxidative Stress and Cancer: Harnessing the Therapeutic Potential of Curcumin and Analogues Against Cancer |
| - | Review, | Var, | NA |
| - | Trial, | BC, | NA |
| - | Trial, | BC, | NA |
| 5065- | dietSTF, | dietFMD, | Nutrition, GH/IGF-I Signaling, and Cancer |
| - | Review, | Var, | NA |
| 5071- | dietSTF, | Unraveling the impact of intermittent fasting in cancer prevention, mitigation, and treatment: A narrative review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6354- | DRE, | Taraxacum officinale L. in leukemia and lymphoma: current knowledge and prospects for horticulture |
| - | Review, | AML, | NA |
| 4914- | DSF, | immuno, | Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies |
| - | Review, | Var, | NA |
| 4916- | DSF, | Cu, | The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics |
| - | Review, | Var, | NA |
| 6611- | Ech, | Proliferative activity of a blend of Echinacea angustifolia and Echinacea purpurea root extracts in human vein epithelial, HeLa, and QBC-939 cell lines, but not in Beas-2b cell lines |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Nor, | HUVECs |
| 6613- | Ech, | Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system |
| - | Study, | Nor, | NA |
| 6603- | Ech, | doxoR, | The effect of Echinacea purpurea on the pharmacokinetics of docetaxel |
| - | Trial, | Var, | NA |
| 6607- | Ech, | Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | CRC, | Colo320 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1332 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid